Federated Hermes, Inc. Axonics, Inc. Transaction History

Federated Hermes, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $1.86 Million - $2.73 Million	-37,210 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $6.39 Million - $8.49 Million	-107,895 Reduced 74.36%	37,210 $2.42 Million
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $2.56 Million - $3.33 Million	-49,728 Reduced 25.52%	145,105 $9.2 Million
Q1 2021 May 13, 2021	BUY	$49.14 - $59.89 $9.57 Million - $11.7 Million	194,833 New	194,833 $11.7 Million
Q4 2020 Feb 12, 2021	SELL	$42.19 - $51.5 $3.74 Million - $4.57 Million	-88,706 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$35.33 - $51.04 $3.13 Million - $4.52 Million	88,621 Added 104260.0%	88,706 $4.53 Million
Q2 2020 Aug 13, 2020	BUY	$22.91 - $39.83 $1,947 - $3,385	85 New	85 $3,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.